Author

Lorna Morris

Berlin Institute of Health at Charité - Universitätsmedizin BerlinORCID 0000-0002-3441-803XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:long-read sequencing· 1 Organism:mouse· 1

Frequent Co-Authors

Agata RakszewskaiD· 1 shared Alexander E KeliD· 1 shared Barry James CampbelliD· 1 shared Carrie A. DuckworthiD· 1 shared Chris Probert· 1 shared Christian ConradiD· 1 shared David G. SpilleriD· 1 shared David Mark PritchardiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Agata RakszewskaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintSep 23, 2025

Long-read single-cell RNA sequencing uncovers cell-type specific transcript regulation in COVID-19

Kristin Köhler, Lorna Morris, Agata Rakszewska…·Christian Conrad

This study uses long-read single-cell RNA sequencing to identify cell-type specific alternative splicing changes in COVID-19 patients compared to healthy controls.

DOI 10.1101/2025.09.23.676511

humanscRNA-seq

𝕏 PostBluesky

Systems BiologyDisease Models & MechanismsPeer-reviewedSep 21, 2020

Identification of a novel therapeutic agent for Inflammatory Bowel Disease guided by systems medicine

Katie Lloyd, Stamatia Papoutsopoulou, Emily Smith…·Michael David Burkitt

This study identifies clarithromycin as a potential therapeutic for inflammatory bowel disease through in-silico drug repositioning and experimental validation of its effects on NF-κB signaling.

18 citations

mousestatistical model

𝕏 PostBluesky